Adial Pharmaceuticals Inc

2.15-0.0300-1.38%Vol 152.30K1Y Perf 76.42%
Apr 13th, 2021 14:55 DELAYED
BID2.16 ASK2.19
Open2.20 Previous Close2.18
Pre-Market- After-Market-
 - -%  - -
Target Price
5.00 
Analyst Rating
— 0.00
Potential %
127.27 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Market Cap37.13M 
Earnings Rating
Neutral
Price Range Ratio 52W %
35.31 
Earnings Date
13th May 2021

Today's Price Range

2.092.27

52W Range

1.144.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-13.15%
1 Month
-15.18%
3 Months
4.81%
6 Months
10.10%
1 Year
76.42%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ADIL2.15-0.0300-1.38
AAPL134.353.11002.37
GOOG2 271.5816.79000.74
MSFT258.302.39000.93
XOM55.700.20000.36
WFC39.87-0.9000-2.21
JNJ159.52-2.1200-1.31
FB311.860.32000.10
GE13.50-0.0900-0.66
JPM154.82-1.1300-0.72
Earnings HistoryEstimateReportedSurprise %
Q02 2020--0.16-
Q01 2020--0.22-
Q03 2019--0.17-
Q02 2019--0.21-
Q01 2019--0.33-
Q03 2018-0.31-0.85-174.19
----
----
Earnings Per EndEstimateRevision %Trend
12/2019 FY-1.000.00-
----
----
----
Next Report Date13th May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume152.30K
Shares Outstanding17.27M
Trades Count431
Dollar Volume4.41M
Avg. Volume637.10K
Avg. Weekly Volume148.13K
Avg. Monthly Volume290.59K
Avg. Quarterly Volume642.38K

Adial Pharmaceuticals Inc (NASDAQ: ADIL) stock closed at 2.18 per share at the end of the most recent trading day (a -8.4% change compared to the prior day closing price) with a volume of 271.62K shares and market capitalization of 37.13M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 4 people. Adial Pharmaceuticals Inc CEO is William B. Stilley.

The one-year performance of Adial Pharmaceuticals Inc stock is 76.42%, while year-to-date (YTD) performance is 28.24%. ADIL stock has a five-year performance of %. Its 52-week range is between 1.14 and 4, which gives ADIL stock a 52-week price range ratio of 35.31%

Adial Pharmaceuticals Inc currently has a PE ratio of -2.80, a price-to-book (PB) ratio of 10.48, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -165.41%, a ROC of -120.72% and a ROE of -195.80%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Adial Pharmaceuticals Inc, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Adial Pharmaceuticals Inc’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Adial Pharmaceuticals Inc is (0), with a target price of $5, which is +127.27% compared to the current price. The earnings rating for Adial Pharmaceuticals Inc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Adial Pharmaceuticals Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Adial Pharmaceuticals Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 24.36, ATR14 : 0.31, CCI20 : -147.97, Chaikin Money Flow : -0.16, MACD : -0.08, Money Flow Index : 31.64, ROC : -3.11, RSI : 40.37, STOCH (14,3) : 6.98, STOCH RSI : 0.26, UO : 32.60, Williams %R : -93.02), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Adial Pharmaceuticals Inc in the last 12-months were: Bankole A. Johnson (Sold 700 000 shares of value $847 000 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is an approved drug for treating nausea and emesis.

CEO: William B. Stilley

Telephone: +1 434 422-9800

Address: 1001 Research Park Boulevard, Charlottesville 22911, VA, US

Number of employees: 4

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

56%44%

Bearish Bullish

47%53%

Bearish Bullish

47%53%

News

Stocktwits